Literature DB >> 31665360

Searching for Improved Flu Vaccines-The Time Is Now.

Robert L Atmar1, Wendy A Keitel1.   

Abstract

Keywords:  H3N2; Influenza; influenza vaccine; vaccine effectiveness

Mesh：

Substances：

Year:  2020        PMID： 31665360     DOI： 10.1093/infdis/jiz545

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  39 in total

1.  Longitudinal tobit regression: a new approach to analyze outcome variables with floor or ceiling effects.

Authors:  Jos Twisk; Frank Rijmen
Journal:  J Clin Epidemiol       Date:  2009-02-10       Impact factor: 6.437

2.  Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers.

Authors:  G Lawrence; Q Q Cheng; C Reed; D Taylor; A Stowers; N Cloonan; C Rzepczyk; A Smillie; K Anderson; D Pombo; A Allworth; D Eisen; R Anders; A Saul
Journal:  Vaccine       Date:  2000-03-17       Impact factor: 3.641

3.  Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites.

Authors:  Philip Bejon; Laura Andrews; Rikke F Andersen; Susanna Dunachie; Daniel Webster; Michael Walther; Sarah C Gilbert; Tim Peto; Adrian V S Hill
Journal:  J Infect Dis       Date:  2005-01-07       Impact factor: 5.226

4.  Sterile protection against human malaria by chemoattenuated PfSPZ vaccine.

Authors:  Benjamin Mordmüller; Güzin Surat; Heimo Lagler; Sumana Chakravarty; Andrew S Ishizuka; Albert Lalremruata; Markus Gmeiner; Joseph J Campo; Meral Esen; Adam J Ruben; Jana Held; Carlos Lamsfus Calle; Juliana B Mengue; Tamirat Gebru; Javier Ibáñez; Mihály Sulyok; Eric R James; Peter F Billingsley; K C Natasha; Anita Manoj; Tooba Murshedkar; Anusha Gunasekera; Abraham G Eappen; Tao Li; Richard E Stafford; Minglin Li; Phil L Felgner; Robert A Seder; Thomas L Richie; B Kim Lee Sim; Stephen L Hoffman; Peter G Kremsner
Journal:  Nature       Date:  2017-02-15       Impact factor: 49.962

5.  A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs.

Authors:  James S McCarthy; Silvana Sekuloski; Paul M Griffin; Suzanne Elliott; Nanette Douglas; Chris Peatey; Rebecca Rockett; Peter O'Rourke; Louise Marquart; Cornelius Hermsen; Stephan Duparc; Jörg Möhrle; Katharine R Trenholme; Andrew J Humberstone
Journal:  PLoS One       Date:  2011-08-22       Impact factor: 3.240

6.  Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909.

Authors:  Christopher J A Duncan; Susanne H Sheehy; Katie J Ewer; Alexander D Douglas; Katharine A Collins; Fenella D Halstead; Sean C Elias; Patrick J Lillie; Kelly Rausch; Joan Aebig; Kazutoyo Miura; Nick J Edwards; Ian D Poulton; Angela Hunt-Cooke; David W Porter; Fiona M Thompson; Ros Rowland; Simon J Draper; Sarah C Gilbert; Michael P Fay; Carole A Long; Daming Zhu; Yimin Wu; Laura B Martin; Charles F Anderson; Alison M Lawrie; Adrian V S Hill; Ruth D Ellis
Journal:  PLoS One       Date:  2011-07-22       Impact factor: 3.240

7.  A Randomized Trial Evaluating the Prophylactic Activity of DSM265 Against Preerythrocytic Plasmodium falciparum Infection During Controlled Human Malarial Infection by Mosquito Bites and Direct Venous Inoculation.

Authors:  Sean C Murphy; Elizabeth R Duke; Kelly J Shipman; Ryan L Jensen; Youyi Fong; Sue Ferguson; Holly E Janes; Kevin Gillespie; Annette M Seilie; Amelia E Hanron; Laurie Rinn; Matthew Fishbaugher; Tracie VonGoedert; Emma Fritzen; Stefan H Kappe; Ming Chang; Jason C Sousa; Sean R Marcsisin; Stephan Chalon; Stephan Duparc; Nicola Kerr; Jörg J Möhrle; Nicole Andenmatten; Thomas Rueckle; James G Kublin
Journal:  J Infect Dis       Date:  2018-02-14       Impact factor: 5.226

8.  Comparison of modeling methods to determine liver-to-blood inocula and parasite multiplication rates during controlled human malaria infection.

Authors:  Alexander D Douglas; Nick J Edwards; Christopher J A Duncan; Fiona M Thompson; Susanne H Sheehy; Geraldine A O'Hara; Nicholas Anagnostou; Michael Walther; Daniel P Webster; Susanna J Dunachie; David W Porter; Laura Andrews; Sarah C Gilbert; Simon J Draper; Adrian V S Hill; Philip Bejon
Journal:  J Infect Dis       Date:  2013-04-09       Impact factor: 5.226

9.  Vector transmission regulates immune control of Plasmodium virulence.

Authors:  Philip J Spence; William Jarra; Prisca Lévy; Adam J Reid; Lia Chappell; Thibaut Brugat; Mandy Sanders; Matthew Berriman; Jean Langhorne
Journal:  Nature       Date:  2013-05-29       Impact factor: 49.962

10.  A controlled human malaria infection model enabling evaluation of transmission-blocking interventions.

Authors:  Katharine A Collins; Claire Yt Wang; Matthew Adams; Hayley Mitchell; Melanie Rampton; Suzanne Elliott; Isaie J Reuling; Teun Bousema; Robert Sauerwein; Stephan Chalon; Jörg J Möhrle; James S McCarthy
Journal:  J Clin Invest       Date:  2018-03-12       Impact factor: 14.808
View more
  1 in total

Review 1.  Subdominance in Antibody Responses: Implications for Vaccine Development.

Authors:  Gunnar Lindahl
Journal:  Microbiol Mol Biol Rev       Date:  2020-11-25       Impact factor: 11.056
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.